Fibroblast growth factor-19: Development, analytical characterization and clinical evaluation of a new ELISA test

Author： Stejskal D. Karpisek M. Hanulova Z. Stejskal P.

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.68, Iss.6, 2008-10, pp. : 501-507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Commentary: fibroblast growth factor 19 in patients with bile acid diarrhoea

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 10, 2013-11 ,pp. : 1320-1321

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pleiotropic Functions of Fibroblast Growth Factor Signaling in Embryonic Mammary Gland Development

By Kim Eun-Jung

Journal of Mammary Gland Biology and Neoplasia, Vol. 18, Iss. 2, 2013-06 ,pp. : 139-142

Springer Publishing Company

Access to resources Recommend Favorite

Fibroblast growth factor 19 meets mammalian target of rapamycin: A mitogenic Tête‐à‐Tête under consideration

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1028-1030

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mechanistic target of rapamycin complex 1 is an essential mediator of metabolic and mitogenic effects of fibroblast growth factor 19 in hepatoma cells

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1289-1301

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 2, 2018-02 ,pp. : 342-349

John Wiley & Sons Inc

Access to resources Recommend Favorite